Current Understanding of “Mixed Corticomedullary Adrenal Tumor” and an Insight into Genomic Profiling

Background: Malignant mixed corticomedullary adrenal tumors (MCMTs) are extremely rare, with limited cases reported in the literature. The pathophysiology of malignant MCMTs is not well understood; the most prevailing theories are that it is a composite tumor of embryologically derived mesodermal (adrenal cortex) and neural crest (medulla) origin, perpetuating as two distinct cell lines forming a singular mass. Clinical features and laboratory diagnosis are associated with hypersecretions of the adrenal cortex and medulla. Surgical resection is curative in an isolated tumor. We reviewed and compared cases in the literature highlighting the pathogenesis and genetics of benign and malignant MCMT. Methods: Comprehensive literature analysis was conducted on PubMed and all the cases of mixed corticomedullary adrenal tumor published in English were included. Results: Most patients were female (73.1%) with a median age of 49 in women and 50 in men. Surgery was performed in all patients, and in four patients with malignant disease, chemotherapy was used as well. Clinically, most patients presented with hypertension (69%) followed by Cushing syndrome (42%) and diabetes (19%). Tumors often produced cortisol (74%), catecholamines (50%), and adrenocorticotrophic hormone (ACTH) (38%), with lower incidence of aldosterone- (7%) or dopamine (4%)-producing tumors. Immunohistochemical staining of 96% of cases showed Chromogranin-A (73%) and Synaptophysin (62%), followed by Inhibin-α (50%), Melan-A (31%), and S-100 (23%). Of the reported four cases with malignant disease, three showed a Ki-67 index of 40–50% with one showing less than 5%. Conclusion: Mixed corticomedullary adrenal tumors rarely present as a malignant disease requiring chemotherapy. Most MCMTs confer a good prognosis and respond well to surgical resection, though their pathogenesis is largely up to speculation because of limited data. Current theories regarding MCMT pathogenesis should be investigated further with genetic testing. Future research on MCMT may provide ways to guide physician diagnosis and subsequent treatment for refractory cases.

[1]  T. Motoyama,et al.  Mixed corticomedullary tumor of the adrenal gland , 2022, Frontiers in Endocrinology.

[2]  M. Fujisawa,et al.  Adrenal Corticomedullary Mixed Tumor Associated With the FGFR4-G388R Variant , 2020, Journal of the Endocrine Society.

[3]  K. Kuo,et al.  Stemness regulation of the adrenal mixed corticomedullary tumorigenesis-a case-control study , 2020, Neoplasia.

[4]  Claudia Ramírez-Rentería,et al.  From ACTH-Dependent to ACTH-Independent Cushing's Syndrome from a Malignant Mixed Corticomedullary Adrenal Tumor: Potential Role of Embryonic Stem Cells , 2020, Case reports in endocrinology.

[5]  Hongting Zheng,et al.  Corticomedullary mixed tumour resembling a small adrenal gland-involvement of cancer stem cells: case report , 2017, BMC Endocrine Disorders.

[6]  Mhd Belal Alsabek,et al.  Mixed corticomedullary adrenal carcinoma – case report: Comparison in features, treatment and prognosis with the other two reported cases , 2017, International journal of surgery case reports.

[7]  Thinzar M. Lwin,et al.  Adrenal Cushing syndrome with detectable ACTH from an unexpected source , 2016, BMJ Case Reports.

[8]  G. Mills,et al.  Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications , 2014, PloS one.

[9]  Dachun Zhao,et al.  Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers , 2013, Histopathology.

[10]  S. Aubert,et al.  Corticomedullary mixed tumor of the adrenal gland—a clinical and pathological chameleon: case report and review of literature , 2013, Updates in Surgery.

[11]  G. Karayannopoulou,et al.  Mixed corticomedullary adrenal carcinoma , 2013, Surgery Today.

[12]  Y. Homma,et al.  Dopamine‐secreting corticomedullary mixed tumor of the adrenal gland , 2012, International journal of urology : official journal of the Japanese Urological Association.

[13]  V. Livolsi,et al.  Mixed corticomedullary carcinoma of the adrenal gland: a case report. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[14]  P. Chu,et al.  Mixed cortical adenoma and composite pheochromocytoma-ganglioneuroma: an unusual corticomedullary tumor of the adrenal gland. , 2011, Annals of diagnostic pathology.

[15]  Meeta Singh,et al.  Mixed corticomedullary tumour with myelolipoma: a rare coexistence. , 2010, Pathology.

[16]  M. Mokni,et al.  Corticomedullary mixed tumor of the adrenal gland. , 2009, Annales d'endocrinologie.

[17]  H. Sasano,et al.  Image in endocrinology. Pheochromocytoma with subclinical Cushing's syndrome caused by corticomedullary mixed tumor of the adrenal gland. , 2009, The Journal of clinical endocrinology and metabolism.

[18]  S. Tseleni-Balafouta,et al.  Corticomedullary mixed adrenal tumor: case report and literature review. , 2009, Endocrine journal.

[19]  G. Falk,et al.  Phaeochromocytoma and mixed corticomedullary tumour – a rare cause of Cushing's syndrome and labile hypertension in a primigravid woman postpartum , 2008, Clinical endocrinology.

[20]  Liang-Yu Lin,et al.  Coexistence of Adrenal Cushing Syndrome and Pheochromocytoma in a “Corticomedullary Adenoma”: A Case Report and Review of the Literature , 2007 .

[21]  D. Fraker,et al.  Corticomedullary mixed tumor of the adrenal gland with concurrent adrenal myelolipoma. , 2009, Archives of pathology & laboratory medicine.

[22]  L. Thompson,et al.  Corticomedullary mixed tumor of the adrenal gland. , 2001, Annals of diagnostic pathology.

[23]  Takeo Iwama,et al.  Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.

[24]  B. Nordlinger,et al.  [Mixed corticomedullary tumor]. , 1998, Presse medicale.

[25]  M. Michal,et al.  Corticomedullary tumors of the adrenal glands. Report of two cases. Association of corticomedullary tumor with spindle cell sarcoma. , 1996, Pathology, research and practice.

[26]  O. Murakami,et al.  [A case of adrenal mixed tumor of pheochromocytoma and adrenocortical adenoma presenting diabetes mellitus and hypertension]. , 1993, Nihon Naibunpi Gakkai zasshi.

[27]  D. A. Mathison,et al.  Cushing's syndrome with hypertensive crisis and mixed adrenal cortical adenoma-pheochromocytoma (corticomedullary adenoma). , 1969, The American journal of medicine.

[28]  John H. Jopson,et al.  A REPORT OF TWO CASES , 1902 .